Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 78,868 | 60,360 | 61,666 | 67,151 | 47,156 |
| Marketable Securities | N/A | N/A | 35,000 | 65,580 | 90,116 |
| Receivables | 111,498 | 108,384 | 81,389 | 71,688 | 65,639 |
| Inventories | 115,926 | 98,804 | 95,996 | 69,369 | 76,424 |
| Income taxes - deferred | 21,477 | 23,606 | 16,884 | 13,778 | 13,460 |
| Other current assets | 28,121 | 14,509 | 11,328 | 11,679 | 8,797 |
| TOTAL | $355,890 | $305,663 | $302,263 | $299,245 | $301,592 |
| Non-Current Assets | |||||
| PPE Net | 189,646 | 141,852 | 99,628 | 65,697 | 62,630 |
| Investments And Advances | 0 | 0 | 0 | 0 | 19,687 |
| Intangibles | 207,095 | 236,414 | 157,669 | 118,746 | 124,494 |
| Other Non-Current Assets | 12,806 | 18,250 | 0 | 6,988 | 5,834 |
| TOTAL | $409,547 | $396,516 | $257,297 | $191,431 | $212,645 |
| Total Assets | $765,437 | $702,179 | $559,560 | $490,676 | $514,237 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 765 | 720 | 678 | 551 | N/A |
| Accounts payable and accrued liabilities | 28,006 | 32,510 | 24,374 | 19,842 | 14,723 |
| Accrued Expenses | 91,292 | 89,042 | 72,250 | 56,057 | 55,539 |
| Other current liabilities | N/A | N/A | N/A | 2,191 | 2,785 |
| TOTAL | $295,292 | $223,392 | $124,743 | $106,566 | $99,952 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,094 | 5,727 | 6,447 | N/A | 519 |
| Deferred Revenues | 11,285 | 10,678 | 8,976 | 7,965 | 10,153 |
| Other Non-Current Liabilities | 11,137 | 13,830 | 4,521 | 1,268 | 1,403 |
| TOTAL | $31,951 | $40,464 | $24,956 | $15,100 | $16,625 |
| Total Liabilities | $327,243 | $263,856 | $149,699 | $121,666 | $116,577 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 118,258 | 121,909 | 124,554 | 127,409 | 131,636 |
| Common Shares | 9,539 | 9,450 | 9,324 | 4,594 | 4,522 |
| Retained earnings | 702,031 | 585,862 | 490,614 | 396,936 | 318,682 |
| Other shareholders' equity | 8,932 | 25,238 | 12,592 | 2,086 | 11,639 |
| TOTAL | $438,194 | $438,323 | $409,861 | $369,010 | $397,660 |
| Total Liabilities And Equity | $765,437 | $702,179 | $559,560 | $490,676 | $514,237 |